<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>1000 Green Steps &#187; Flomax generic</title>
	<atom:link href="http://1000greensteps.org/tag/flomax-generic/feed/" rel="self" type="application/rss+xml" />
	<link>http://1000greensteps.org</link>
	<description>New Green Business Ideas</description>
	<lastBuildDate>Fri, 10 Sep 2010 22:28:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>US regulator disapproves Ranbaxy&#8217;s report to launch Flomax generic</title>
		<link>http://1000greensteps.org/2010/08/27/us-regulator-disapproves-ranbaxys-report-to-launch-flomax-generic/</link>
		<comments>http://1000greensteps.org/2010/08/27/us-regulator-disapproves-ranbaxys-report-to-launch-flomax-generic/#comments</comments>
		<pubDate>Fri, 27 Aug 2010 12:41:54 +0000</pubDate>
		<dc:creator>Nitin</dc:creator>
				<category><![CDATA[Cosumer-driven]]></category>
		<category><![CDATA[News - Environment and Health]]></category>
		<category><![CDATA[Flomax generic]]></category>
		<category><![CDATA[Ranbaxy]]></category>

		<guid isPermaLink="false">http://1000greensteps.org/?p=2120</guid>
		<description><![CDATA[
Ranbaxy Laboratories reported on Wednesday that it would not be able to launch a generic version of a urinary drug in the United States as per schedule in the absence of a final approval from the regulator.
Ranbaxy is India&#8217;s largest drug maker and they expected to launch the cheaper copycat version of Astellas Pharma&#8217;s (4503.T) [...]]]></description>
			<content:encoded><![CDATA[<p><img class="aligncenter size-full wp-image-2122" src="http://1000greensteps.org/wp-content/uploads/2010/03/11.jpg" alt="11" width="230" height="230" /></p>
<p>Ranbaxy Laboratories reported on Wednesday that it would not be able to launch a generic version of a urinary drug in the United States as per schedule in the absence of a final approval from the regulator.<span id="more-2120"></span></p>
<p>Ranbaxy is India&#8217;s largest drug maker and they expected to launch the cheaper copycat version of Astellas Pharma&#8217;s (4503.T) Flomax in the United States this month.</p>
<p>â€œWe regret that despite our best efforts we were not able to get an approval for the subject product, and hence will not be in a position to launch the product,&#8221; Ranbaxy said in a statement, referring to the drug.â€ They did not give any reasons for not getting the approval.</p>
]]></content:encoded>
			<wfw:commentRss>http://1000greensteps.org/2010/08/27/us-regulator-disapproves-ranbaxys-report-to-launch-flomax-generic/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
